Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response

Journal of Physiology

Volumn 513, Issue 3, 1998, Pages 655-670

  Figl, Antonio ^a   Viseshakul, Nareerat ^a   Shafaee, Navid ^a   Forsayeth, John ^b   Cohen, Bruce N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neurex Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCIUM ION; CELL SURFACE RECEPTOR; NEUROTRANSMITTER; NICOTINIC RECEPTOR; PROTEIN SUBUNIT;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONDUCTANCE; CONTROLLED STUDY; DESENSITIZATION; EXTRACELLULAR CALCIUM; FRONTAL LOBE EPILEPSY; GENE MUTATION; HUMAN; NEUROTRANSMITTER RELEASE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; XENOPUS; BINDING KINETICS; CAUSAL ATTRIBUTION; EXPOSURE; MUTATIONAL ANALYSIS; NERVE ENDING; STEADY STATE; SYNAPTIC TRANSMISSION;

ALGORITHMS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CALCIUM; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EPILEPSY, FRONTAL LOBE; HUMANS; IODINE RADIOISOTOPES; ION CHANNELS; MEMBRANE POTENTIALS; MUTATION; NICOTINIC AGONISTS; OOCYTES; PATCH-CLAMP TECHNIQUES; PYRIDINES; RATS; RECEPTORS, NICOTINIC; XENOPUS;

EID: 0032535596     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1998.655ba.x     Document Type: Article

References (39)

1. ADAMS, P. R. & FELTZ, A. (1977). Interaction of a fluorescent probe with acetylcholine-activated synaptic membrane. Nature 269, 609-611.
2. BADIO, B. & DALY, J. W. (1994). Epibatidine, a potent analgetic and nicotinic agonist. Molecular Pharmacology 45, 563-569.
3. BUISSON, B., GOPALAKRISHNAN, M., ARNERIC, S. P., SULLIVAN, J. P. & BERTRAND, D. (1996). Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch clamp study. Journal of Neuroscience 16, 7880-7891.
4. CHARNET, P., LABARCA, C., COHEN, B. N., DAVIDSON, N., LESTER, H. A. & PILAR, G. (1992). Pharmacological and kinetic properties of α4β2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. Journal of Physiology 450, 375-394.
5. CLEMENTS, J. D. (1996). Transmitter time course in the synaptic cleft: its role in central synaptic function. Trends in Neurosciences 19, 163-171.
6. COHEN, B. N., FIGL, A., QUICK, M. W., LABARCA, C., DAVIDSON, N. & LESTER, H. A. (1995). Regions of β2 and β4 responsible for differences between the steady state dose-response relationships of the α3β2 and α3β4 neuronal nicotinic receptors. Journal of General Physiology 105, 745-764.
7. COLQUHOUN, D. & SIGWORTH, F. (1995). Fitting and statistical analysis of single-channel records. In Single-Channel Recording, ed. SAKMANN, B. & NEHER, E., pp. 483-587. Plenum Press, New York.
8. EDMONDS, B., GIBB, A. J. & COLQUHOUN, D. (1995). Mechanisms of activation of muscle nicotinic acetylcholine receptors and the time course of endplate currents. Annual Review of Physiology 57, 469-493.
9. EILERS, H., SCHAEFFER, E., BICKLER, P. E. & FORSAYETH, J. R. (1997). Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Molecular Pharmacology 52, 1105-1112.
10. FIGL, A., LABARCA, C., DAVIDSON, N., LESTER, H. A. & COHEN, B. N. (1996). Voltage-jump relaxation kinetics for wild-type and chimeric β subunits of neuronal nicotinic receptors. Journal of General Physiology 107, 369-379.
11. FIGL, A., VISESHAKUL, N., FORSAYETH, J. & COHEN, B. N. (1997). A mutation associated with epilepsy enhances desensitization of the α4β2 neuronal nicotinic receptor. Biophysical Journal 72, A150.
12. FLORES, C. M., ROGERS, S. W., PABREZA, L. A., WOLFE, B. B. & KELLAR, K. J. (1991). A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Molecular Pharmacology 41, 31-37.
13. FRANKE, C., PARNAS, H., HOVAV, G. & DUDEL, J. (1993). A molecular scheme for the reaction between acetylcholine and nicotinic channels. Biophysical Journal 64, 339-356.
14. GERZANICH, V., PENG, X., WANG, F., WELLS, G., ANAND, R., FLETCHER, S. & LINDSTROM, J. (1995). Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Molecular Pharmacology 48, 774-782.
15. GUYTON, A. C. & HALL, J. E. (1996). Textbook of Medical Physiology, p. 986. W. B. Saunders, Philadelphia, PA, USA.
16. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Molecular Pharmacology 48, 280-287.
17. IFUNE, C. K. & STEINBACH, J. H. (1992). Inward rectification of acetylcholine-elicited currents in rat phaeochromocytoma cells. Journal of Physiology 457, 143-165.
18. JOBLING, S. A. & GEHRKE, L. (1987). Enhanced translation of chimaeric messenger RNAs containing a plant viral untranslated leader sequence. Nature 325, 622-625.
19. KARLIN, A. & AKABAS, M. H. (1995). Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15, 1231-1244.
20. KATZ, B. & THESLEFF, S. (1957). A study of the 'desensitization' produced by acetylcholine at the motor end-plate. Journal of Physiology 138, 63-80.
21. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. Journal of Neuroscience 17, 9035-9047.
22. LEWIS, T. M., HARKNESS, P. C., SIVILOTTI, L. G., COLQUHOUN, D. & MILLAR, N. S. (1997). The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type. Journal of Physiology 505, 299-306.
23. LOPATIN, A. N., MAKHINA, E. N. & NICHOLS, C. G. (1994). Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 24, 366-369.
24. MULLE, C., LENA, C. & CHANGEUX, J.-P. (1992). Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron 8, 937-945.
25. PENG, X., GERZANICH, B., ANAND, R., WHITING, P. J. & LINDSTROM, J. (1994). Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Molecular Pharmacology 46, 523-530.
26. QUICK, M. W. & LESTER, H. A. (1994). Methods for expression of excitability proteins in Xenopus oocytes. In Methods in Neurosciences, vol. 19, ed. CONN, P. M., pp. 261-279. Academic Press, San Diego.
27. SANDS, S. B., COSTA, A. C. S. & PATRICK, J. (1993). Barium permeability of neuronal nicotinic receptor α7 expressed in Xenopus oocytes. Biophysical Journal 65, 2614-2621.
28. SCHEFFER, I. E., BHATIA, K. P., LOPEZ-CENDES, I., FISH, D. R., MARSDEN, D., ANDERMANN, E., ANDERMANN, R., DESBIENS, R., KEENE, D., CENDES, F., MANSON, J. I., CONSTANTINOU, J. E. C., MCINTOSH, A. & BERKOVIC, S. F. (1995). Autosomal dominant nocturnal frontal lobe epilepsy: a distinctive clinical disorder. Brain 118, 61-73.
29. 2+ in vasopressin neurons. Neuroscience Research 29, 311-318.
30. STEINLEIN, O. K., MAGNUSSON, A., STOODT, J., BERTRAND, S., WEILAND, S., BERKOVIC, S. F., NAKKEN, K. O., PROPPING, P. & BERTRAND, D. (1997). An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Human Molecular Genetics 6, 943-947.
31. STEINLEIN, O. K., MULLEY, J. C., PROPPING, P., WALLACE, R. H., PHILLIPS, H. A., SUTHERLAND, G. R., SCHEFFER, I. E. & BERKOVIC, S. F. (1995). A missense mutation in the neuronal nicotinic aeetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genetics 11, 201-203.
32. VIBAT, C. R. T., LASALDE, J. A., MCNAMEE, M. G. & OCHOA, E. L. M. (1995). Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus oocytes. Cellular and Molecular Neurobiology 15, 411-425.
33. WEILAND, S., WITZEMANN, V., VILLAROEL, A., PROPPING, P. & STEINLEIN, O. (1996). An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Letters 398, 91-96.
34. WHITING, P. & LINDSTROM, J. (1987). Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proceedings of the National Academy of Sciences of the USA 84, 595-599.
35. WHITING, P. J. & LINDSTROM, J. (1988). Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. Journal of Neuroscience 8, 3395-3404.
36. WHITING, P., SCHOEPFER, R., LINDSTROM, J. & PRIESTLEY, T. (1991). Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Molecular Pharmacology 40, 463-472.
37. 4, expressed in transfected eucaryotic cells. Molecular Brain Research 28, 101-109.
38. WONNACOTT, S. (1997). Presynaptic nicotinic ACh receptors. Trends in Neurosciences 20, 92-98.
39. ZAGOTTA, W. N., HOSHI, T. & ALDRICH, R. W. (1990). Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB. Science 250, 568-571.